cysteamine has been researched along with Bone Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bacchetta, J; Bertholet-Thomas, A; Carlier, MC; Claramunt-Taberner, D; Cochat, P; Cohen-Solal, M; DeschĂȘnes, G; Gaillard, S; Pelletier, S; Sornay-Rendu, E; Szulc, P | 1 |
Ariceta, G; Awan, A; Bacchetta, J; Bechtold, S; Bergmann, C; Cassidy, N; Deschenes, G; Elenberg, E; Gahl, WA; Greil, O; Haffner, D; Harms, E; Herzig, N; Hohenfellner, K; Hoppe, B; Koeppl, C; Levtchenko, E; Lewis, MA; Nesterova, G; Rauch, F; Santos, F; Schlingmann, KP; Servais, A; Soliman, NA; Steidle, G; Sweeney, C; Topaloglu, R; Treikauskas, U; Tsygin, A; V Vigier, R; Veys, K; Zustin, J | 1 |
Aina, V; Cerrato, G; Lusvardi, G; Magistris, C; Malavasi, G; Martra, G; Menabue, L; Viscardi, G | 1 |
LETIZIA, G; PATANIA, S | 1 |
1 trial(s) available for cysteamine and Bone Diseases
Article | Year |
---|---|
Teenagers and young adults with nephropathic cystinosis display significant bone disease and cortical impairment.
Topics: Absorptiometry, Photon; Adolescent; Adult; Age Factors; Biomarkers; Bone Density; Bone Diseases; Child; Cortical Bone; Cysteamine; Cystinosis; Female; Fibroblast Growth Factor-23; Humans; Male; Pilot Projects; Prevalence; Prospective Studies; Quality of Life; Radius; Severity of Illness Index; Tibia; Tomography, X-Ray Computed; Young Adult | 2018 |
3 other study(ies) available for cysteamine and Bone Diseases
Article | Year |
---|---|
Management of bone disease in cystinosis: Statement from an international conference.
Topics: Administration, Oral; Bone Diseases; Cysteamine; Cystinosis; Disease Management; Fanconi Syndrome; Female; Humans; Male | 2019 |
New formulation of functionalized bioactive glasses to be used as carriers for the development of pH-stimuli responsive biomaterials for bone diseases.
Topics: Animals; Biocompatible Materials; Bone Diseases; Cysteamine; Drug Delivery Systems; Fluoresceins; Glass; Humans; Hydrogen-Ion Concentration | 2014 |
[Action of beta-mercaptoethylamine on the reparative process in experimental bone lesions].
Topics: Animals; Bone Diseases; Cartilage Diseases; Cysteamine; Fractures, Bone; Mercaptoethylamines | 1961 |